However, a number of key proinflammatory cytokines, such as IL-1β and IL-6, have been reported to promote tumor progression through the mobilization of MDSCs (40, 41), the contribution to chronic inflammation (40, 42) and the stimulation of angiogenesis (43, 44). The gene discussed is IL6; the disease is neoplasm.